Unum Therapeutics - 48 Year Dividend History | UMRX

Historical dividend payout and yield for Unum Therapeutics (UMRX) since 1971. The current TTM dividend payout for Unum Therapeutics (UMRX) as of June 17, 2019 is $0.00. The current dividend yield for Unum Therapeutics as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.073B $0.010B
Unum Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel immunotherapy products of immune system to cure cancer. The company's program consists of ACTR087 rituximab, ACTR707 RITUXIMAB, ACTR087 SEA-BCMA which are in clinical stage. Unum Therapeutics Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83